Detalhe da pesquisa
1.
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
Breast Cancer Res Treat
; 194(1): 159-170, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507134
2.
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
J Natl Cancer Inst
; 115(11): 1318-1328, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369040
3.
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.
Breast
; 61: 98-107, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929424
4.
Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
Cancers (Basel)
; 13(11)2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34063736
5.
The effect of hormone therapy on breast density following risk-reducing salpingo-oophorectomy in women with an increased risk for breast and ovarian cancer.
Menopause
; 28(11): 1307-1312, 2021 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374687
6.
The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer.
Breast
; 52: 102-109, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497987
7.
Corrigendum to "The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer" [Breast 52 (2020) 102-109].
Breast
; 53: 221-222, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950229